Find your path to Stephan
479 people in our graph can introduce you to Stephan.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Lovisa Backemar to introduce you to Stephan
You →Lovisa · together at EIR Ventures (2023–2026) →Stephan
Ask Jamie Chen to introduce you to Stephan
You →Jamie · together at ISD-Immunotech →Stephan
Ask Sam Okafor to introduce you to Stephan
You →Sam · together at IO Biotech →Stephan
Sign up to find every way you can get introduced to Stephan
- Your email: the people you already email who know Stephan
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Stephan
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Holds a PhD in protein chemistry and immunology and has broad executive experience in private and public biotech. A founding member of Novo Seeds at Novo Holdings, he has led the creation and funding of over 30 Nordic life science companies over nearly 20 years.
Contact· self-published, not guessed
Experience
- GutCRINE ApSChairpersoncurrent2023 — present
- HenlezChairpersoncurrent2022 — presentCopenhagen, Capital Region of Denmark, Denmark
- Scenic BiotechDirectorcurrent2022 — present
- Eir VenturesFounding Partnercurrent2020 — present
- OctarineChairpersoncurrent2020 — present
- Venture CupChairman of the Boardcurrent2012 — presentCopenhagen Metropolitan Area
- ISD-ImmunotechMember Board Of Directors2021 — 2023Denmark
- Galecto BiotechBoard Member2011 — 2022Kalmar County, Sweden
- AFYX TherapeuticsBoard Member2017 — 2020Copenhagen Metropolitan Area
- ForendoChairman of the Board2013 — 2020Turku, Finland
- HeparegenixBoard Member2016 — 2019Greater Tubingen Area
- IO BiotechMember Board of Directors2016 — 2019Copenhagen Metropolitan Area
- Macrophage PharmaMember Board Of Directors2016 — 2019
- Novo A/SSenior Partner2007 — 2019Copenhagen Metropolitan Area
- Acesion PharmaBoard Member2015 — 2019Copenhagen Area, Denmark
- LYSOGENEBoard Member2014 — 2018Greater Paris Metropolitan Region
- NMD PharmaMember of the Board of Directors2016 — 2017
- Adenium BiotechBoard Member2011 — 2017Copenhagen Metropolitan Area
- Aros PharmaChairman of the Board2009 — 2015Copenhagen Metropolitan Area
- InagenDirector2008 — 2015Copenhagen Metropolitan Area
Skills & more
+10 more
Corporate DevelopmentDrug DiscoveryBusiness StrategyMergers & AcquisitionsStart-upsTechnology TransferClinical ResearchBiopharmaceuticalsPharmaceutical IndustryStrategyLanguages Danish · English
From Stephan's professional profile.
Deals · 1
Damora TherapeuticsBoard seat
via EIR Ventures · filed Nov 2020 · $64.2M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at EIR Ventures
Frequently asked questions
- Who is Stephan Christgau?
- Holds a PhD in protein chemistry and immunology and has broad executive experience in private and public biotech. A founding member of Novo Seeds at Novo Holdings, he has led the creation and funding of over 30 Nordic life science companies over nearly 20 years.
- Where does Stephan Christgau work?
- Stephan Christgau is Founding Partner at EIR Ventures.
- What boards does Stephan Christgau sit on?
- Stephan Christgau holds tracked board seats at Damora Therapeutics.
- Where did Stephan Christgau go to school?
- Stephan Christgau studied at DTU - Technical University of Denmark; University of California, San Francisco (Biochemistry); Harvard Business School (Strategic Negotiation).
Same school
Also attended DTU - Technical University of Denmark138
+ 132 more
Also attended University of California, San Francisco173
+ 167 more
Also attended Harvard Business School2,000
+ 1,994 more
Shared employers
Also worked at Scenic Biotech10
+ 4 more









































